Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Enhanced diagnostic tools for early detection of resistant strains, coupled with therapeutic strategies that disrupt key resistance pathways, will be essential to ensuring the long-term success of anti-leishmanial therapies and improving patient outcomes
doi: 10.1038/s42255-020-0171-3 41 TschpMHFinanBClemmensenCGelfanovVPerez-TilveDMllerTDet al
WARNING This product should not be taken by those with epilepsy or seizure disorders
Many widely used medications were never FDA-approved for the conditions they treat
US$ 27.60
US$ 21.22
US$ 20.61
US$ 26.19
US$ 25.55
US$ 20.00
US$ 29.61
US$ 20.53
